The introduction of Retatrutide in the nation is sparking significant excitement within the weight management community. This innovative dual medication – targeting both GLP-1 and GIP – promises a potentially new approach to combating obesity . Currently , options have been limited for many, and Retatrutide embodies a hopeful possibility for pe